A C Dijkmans - JoVE Visualize

Showing results (51-60 of 256) with videos related to

Pageof 26

Sort By:

Annals of the Rheumatic Diseases|January 17, 2009

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesG R Burmester, P Mease, B A C Dijkmans, et al.

Annals of the Rheumatic Diseases|July 3, 2007

Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritisK S S Steen, M T Nurmohamed, I Visman, et al.

Current Opinion in Obstetrics & Gynecology|January 18, 2012

Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complicationsAnneke C Dijkmans, Eveline P de Jong, Ben A C Dijkmans, et al.

Clinical Rheumatology|September 4, 2012

Elevated liver enzymes in patients with ankylosing spondylitis treated with etanerceptJ C van Denderen, G J Blom, I E van der Horst-Bruinsma, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 20, 2017

[Measles after MMR-vaccination]R van Grootveld, L M Klitsie, D C M van der Kaay, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Bioassay for detection of methotrexate in serumS de Lathouder, A H Gerards, E R de Groot, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 12, 2005

[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]B A C Dijkmans, D van Schaardenburg, I E van der Horst-Bruinsma, et al.

Clinical and Experimental Rheumatology|May 21, 2010

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitisE Martín-Mola, J Sieper, M Leirisalo-Repo, et al.

Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009

[Methotrexate: safe if prescribed correctly]Monique M Verduijn, Bart J F van den Bemt, Ben A C Dijkmans, et al.

BMC Musculoskeletal Disorders|July 17, 2009

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonatesDanielle A Eekman, Marijn Vis, Irene E M Bultink, et al.

Pageof 26

Showing results (51-60 of 256) with videos related to

Sort By:

Pageof 26

Annals of the Rheumatic Diseases|January 17, 2009

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesG R Burmester, P Mease, B A C Dijkmans, et al.

Annals of the Rheumatic Diseases|July 3, 2007

Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritisK S S Steen, M T Nurmohamed, I Visman, et al.

Current Opinion in Obstetrics & Gynecology|January 18, 2012

Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complicationsAnneke C Dijkmans, Eveline P de Jong, Ben A C Dijkmans, et al.

Clinical Rheumatology|September 4, 2012

Elevated liver enzymes in patients with ankylosing spondylitis treated with etanerceptJ C van Denderen, G J Blom, I E van der Horst-Bruinsma, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 20, 2017

[Measles after MMR-vaccination]R van Grootveld, L M Klitsie, D C M van der Kaay, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Bioassay for detection of methotrexate in serumS de Lathouder, A H Gerards, E R de Groot, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 12, 2005

[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]B A C Dijkmans, D van Schaardenburg, I E van der Horst-Bruinsma, et al.

Clinical and Experimental Rheumatology|May 21, 2010

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitisE Martín-Mola, J Sieper, M Leirisalo-Repo, et al.

Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009

[Methotrexate: safe if prescribed correctly]Monique M Verduijn, Bart J F van den Bemt, Ben A C Dijkmans, et al.

BMC Musculoskeletal Disorders|July 17, 2009

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonatesDanielle A Eekman, Marijn Vis, Irene E M Bultink, et al.

Pageof 26